EUVIMEDEUVIMED entdecken
Crossref

Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation

Atul Prakash, Kaushal Patel iD, Ajitha Virinchipuram Ganesan, Gaurav Patel iD, Darshan Gandhi

Pacing and Clinical Electrophysiology · 25.07.2026

DOI: 10.1111/pace.70374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 25.07.2026. Verfasst von Atul Prakash und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Electrophysiology, St Mary's General Hospital, Passaic, New Jersey, USA. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is increasingly conceptualized as a manifestation of atrial cardiomyopathy characterized by progressive fibrosis and structural remodeling. Systemic inflammation may contribute to AF progression and pathogenesis. Elevated inflammatory biomarkers may represent a pro‐inflammatory state, playing a possible role in AF. Left atrial (LA) scar burden serves as a surrogate for atrial fibrosis; however, its association with inflammatory markers is less well established.

Objectives

The objectives of the study are as follows: To evaluate a possible association between LA scar burden and inflammatory markers. To identify additional markers correlated with higher scar burden.

Methods

We retrospectively analyzed patients undergoing first‐time AF ablation to explore the association between systemic inflammatory markers and LA scar burden. Biomarkers included high‐sensitivity C‐reactive protein (hsCRP), neutrophil‐to‐lymphocyte ratio (NLR), and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP). Demographics, comorbidities, and CHA 2 DS 2 ‐VASc score were recorded. LA scar was quantified during electroanatomic voltage mapping using the BioSense Webster Oct array catheter D1609.

Results

A total of 229 patients with AF were included;107 (46.7%) demonstrated significant atrial scar, while 122 (53.3%) did not have significant scar burden. Of these, 147 patients with complete biomarker data were included in the final analysis. Scar‐present patients had significantly higher NT‐proBNP, hsCRP, and BMI, along with a higher prevalence of dyslipidemia, obstructive sleep apnoea, and hypothyroidism, and a significantly different AF type distribution (all p < 0.05). On univariable logistic regression, significant predictors of atrial scar included NT‐proBNP, BMI, hypothyroidism, Longstanding persistent Atrial Fibrillation (AF LS‐persistent), dyslipidemia, obstructive sleep apnea, and CHA 2 DS 2 ‐VASc score, with hsCRP demonstrating a borderline association ( p = 0.076). On multivariable logistic regression, LS‐persistent AF was the only independent predictor of significant atrial scar ( p = 0.026), while BMI and hypothyroidism showed borderline independent associations ( p < 0.10).

Conclusions

Our findings suggest a possible correlation of inflammatory markers and Left Atrial scar burden. The association of other comorbidities, like higher BMI, hypothyroidism, dyslipidemia, and sleep apnea, with a higher atrial scar burden may be related to myocardial stress. This suggests an interplay of inflammatory markers and comorbidities, which result in a significant scar burden either directly or indirectly

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationatrial fibrosiselectroanatomic voltage mappinghigh‐sensitivity C‐reactive protein (hsCRP)inflammationinflammatory markersleft atrial scarneutrophil‐to‐lymphocyte ratio

Autor:innen und Institutionen

  • Department of Cardiology and Electrophysiology, St Mary's General Hospital, Passaic, New Jersey, USA.
  • Department of Internal Medicine, New York Medical College at St. Mary's General Hospital and St. Clare's Health, New Jersey, USA.

ORCID-Profile: Kaushal Patel, Gaurav Patel

Zitieren

APA

Prakash, A., Patel, K., Ganesan, A. V., Patel, G., & Gandhi, D. (2026). Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70374

Vancouver

Prakash A, Patel K, Ganesan AV, Patel G, Gandhi D. Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70374

BibTeX
@article{Prakash2026,
  author = {Prakash, Atul and Patel, Kaushal and Ganesan, Ajitha Virinchipuram and Patel, Gaurav and Gandhi, Darshan},
  title = {Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70374}
}
Kostenlos starten →